Company intelligence / Profile preview

CornerLoc

Ownership: Private
Development stage: Commercial

Overview

CornerLoc offers a suite of minimally invasive sacroiliac (SI) joint fusion solutions, including the use of cortical bone allografts and 3D printed titanium implants. Their products are designed for outpatient or ambulatory settings, aiming to provide immediate stability and an optimal environment for long-term SI joint fusion. Clinical results highlighted in patient testimonials suggest significant pain relief after failed conservative treatments, but no formal clinical trial data is published on their website.

Therapeutic areas: Rheumatology
Modalities: DeviceAllograft3D printed titanium implant
Industry: Implantable Medical Devices

Drug pipeline

2 assets

CornerLoc graft

Commercial

Indications: Sacroiliac joint dysfunction

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on CornerLoc.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CornerLoc.

Explore the full profile